MedTrace Logo

Endocare Repair Efficacy Skincare Products in the Use of Post-laser Treatment

NCT07442422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-03-02

No results posted yet for this study

Summary

To Evaluate the Efficacy and Safety of Endocare Repair Efficacy Skincare Products in the Repair of Facial Skin Following Ablative Fractional Laser Treatment.

Conditions

  • Laser Treatment

Interventions

COMBINATION_PRODUCT

Active product contained 40% secretion of SCA

One half of the face received the active product contained 40% secretion of SCA covering all lasered areas.

COMBINATION_PRODUCT

Identical-appearing placebo cream

The other half received an identical-appearing placebo cream (a basic moisturizer containing no SCA ingredients, but otherwise matching the active product in appearance and texture), covering all lasered areas.

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-14
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07442422 on ClinicalTrials.gov